ArticleResearch square2025
Brain-cognition relationships and treatment outcome in treatment-resistant late-life depression.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
Older adults with treatment-resistant depression are at significant risk for cognitive impairment. The relationship between treatment response and cognitive function in this population is not well-established. We examined neural correlates of executive and memory function, and their relationship with prospective treatment outcomes. In the context of a longitudinal biomarker study embedded within a multi-center randomized controlled trial for late-life treatment-resistant depression, 397 participants completed baseline neuropsychological testing, and of these 234 adults successfully completed a baseline MRI scan. Multivariate regressions were used to test for brain-cognition associations between memory and executive function and brain functional connectivity, white matter integrity, and gray matter structure. Further, we employed regularized elastic net regressions to identify biomarkers predicting depression remission (MADRS≤10) in the clinical trial. Among participants who completed neuroimaging better cognition was associated with lower connectivity between components of the default mode and the frontoparietal networks and within the frontoparietal network (multivariate r=0.37, p<0.01). Using diffusion imaging data, lower tract integrity in a distributed set of tracts was associated with poorer executive function (multivariate r=0.27, p<0.05). Additionally, gray matter structure was positively associated with cognition (multivariate r=0.38, p<0.05). Education and better structural brain maintenance but not overall health were associated with better cognition. Ongoing treatment resistance was predicted by poorer cognition and gray matter structure. We identified distinct cross-sectional associations between specific neural circuits and variation in cognitive function in people with treatment-resistant late-life depression. We also found worse cognitive function and gray matter structure predicted ongoing treatment resistance to medication offered in the clinical trial.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.